gRNA Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on GRNA Market 

5.1. COVID-19 Landscape: GRNA Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global GRNA Market, By Product & Service Type

8.1. GRNA Market Revenue and Volume Forecast, by Product & Service Type, 2024-2033

8.1.1. Products

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Custom gRNA Synthesis Services

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global GRNA Market, By GRNA Type

9.1. GRNA Market Revenue and Volume Forecast, by GRNA Type, 2024-2033

9.1.1. Research-use

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. GMP-grade

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global GRNA Market, By Application 

10.1. GRNA Market Revenue and Volume Forecast, by Application, 2024-2033

10.1.1. Genome Engineering

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Genome Engineering

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Genome Engineering

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. Epigenetics

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

10.1.5. Others

10.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global GRNA Market, By End-use 

11.1. GRNA Market Revenue and Volume Forecast, by End-use, 2024-2033

11.1.1. Pharmaceutical & Biotechnology Companies

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Academic Research Institutes

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

11.1.3. CMOs & CROs

11.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global GRNA Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.1.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.1.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.1.5.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.1.6.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.1.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.2.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.2.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.2.5.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.2.6.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.2.7.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.2.8.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.2.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.3.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.3.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.3.5.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.3.6.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.3.7.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.3.8.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.3.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.4.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.4.5.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.4.6.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.4.7.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.4.8.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.4.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.5.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.5.5.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)

12.5.6.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)

12.5.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

Chapter 13. Company Profiles

13.1. Synthego

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Abbott

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Horizon Discovery Ltd

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Synbio Technologies

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Takara Bio Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. GENEWIZ (Azenta Life Sciences)

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Merke KGaA

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Jena Bioscience GmbH

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. System Biosciences, LLC

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Agilent Technologies Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms